What is the recommended dose of Toradol (ketorolac) for the management of epiploic appendagitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing of Ketorolac for Epiploic Appendagitis

For epiploic appendagitis, the recommended dose of ketorolac is 30 mg IM every 6 hours for patients under 65 years of age, with a maximum daily dose not exceeding 120 mg and treatment duration not exceeding 5 days. 1

Dosing Guidelines

Standard Dosing (Patients <65 years)

  • Initial dose: 30 mg IM
  • Maintenance: 30 mg IM every 6 hours as needed
  • Maximum daily dose: 120 mg
  • Maximum duration: 5 days

Modified Dosing (Patients ≥65 years, renally impaired, or <50 kg)

  • Initial dose: 15 mg IM
  • Maintenance: 15 mg IM every 6 hours as needed
  • Maximum daily dose: 60 mg
  • Maximum duration: 5 days

Administration Considerations

  • Intramuscular injections should be given slowly and deeply into the muscle 1
  • The analgesic effect begins in approximately 30 minutes with maximum effect in 1-2 hours
  • Duration of analgesic effect is usually 4-6 hours
  • Hypovolemia should be corrected prior to administration of ketorolac

Treatment Approach for Epiploic Appendagitis

Epiploic appendagitis is a self-limited condition that spontaneously resolves within 5-7 days without surgery 2. The primary treatment approach includes:

  1. Pain management: NSAIDs like ketorolac are the mainstay of treatment
  2. Conservative management: No surgical intervention required
  3. Monitoring: Follow-up to ensure resolution of symptoms

Important Precautions

  • Ketorolac should not be used prophylactically to reduce anticipated pain 3
  • It should only be administered under direct medical supervision
  • Patients should be switched to alternative analgesics as soon as possible
  • Avoid concurrent use with other NSAIDs
  • Contraindicated in patients with:
    • History of significant gastrointestinal bleeding
    • Renal compromise
    • Past history of complications related to NSAIDs
    • Allergic reactions to ketorolac, other NSAIDs, or aspirin

Clinical Considerations for Epiploic Appendagitis

Epiploic appendagitis is often misdiagnosed as appendicitis or diverticulitis 4. Key clinical features include:

  • Localized, focal, non-migratory abdominal pain (often in the left lower quadrant)
  • Normal or mildly elevated white blood cell count
  • Absence of fever
  • More common in overweight individuals 5

Accurate diagnosis through imaging is crucial to avoid unnecessary surgical interventions, as this condition can be effectively managed with NSAIDs alone 4.

By following these dosing guidelines for ketorolac, clinicians can provide effective pain management for patients with epiploic appendagitis while minimizing the risk of adverse effects and avoiding unnecessary surgical interventions.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.